Ottawa Hospital Research Institute (OHRI)

Ottawa, Ontario K1H 8L6

1 studies enrolling now · 4 studies all time

What they study most

Myotonic Dystrophy 1, Prostate Cancer, Pulmonary Embolism, Stroke, Acute, Venous Thromboembolism

Studies at this site

• Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer — Recruiting now
• Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1 — Completed
• Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis — Completed
• A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients — Stopped early